Registry of Pediatric Patients Diagnosed With Crohn's Disease in Belgium (Belcro)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition
ClinicalTrials.gov Identifier:
NCT01241058
First received: November 15, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
  Purpose

A registry of pediatric patients (under 18 yrs of age) diagnosed with Crohn's disease was created in Belgium. Over a 2 year period 257 patients are included. These patients will be follow up prospectively during 5 years. Demographic data, family history, disease presentation and disease course including medication are registered in CRF's.


Condition
Description of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible Associations

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Belgian Registry of Pediatric Crohn's Disease

Resource links provided by NLM:


Further study details as provided by Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition:

Primary Outcome Measures:
  • disease course [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    describe patient characteristics, disease fenotype and course


Enrollment: 257
Study Start Date: May 2008
Estimated Study Completion Date: April 2015
Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   1 Year to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

subjects under 18 yrs of age diagnosed with Crohn's disease, living in Belgium

Criteria

Inclusion Criteria:

1-18 yrs old belgian Crohn s disease informed consent

Exclusion Criteria:

no informed consent

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01241058

Locations
Belgium
Bespghan
Leuven, Brabant, Belgium, 3000
Sponsors and Collaborators
Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition
  More Information

No publications provided

Responsible Party: Gigi Veereman, Bespghan
ClinicalTrials.gov Identifier: NCT01241058     History of Changes
Other Study ID Numbers: Bespghan
Study First Received: November 15, 2010
Last Updated: November 15, 2010
Health Authority: Belgium: Institutional Review Board

Keywords provided by Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition:
pediatrics, crohn's disease, disease course, therapy

Additional relevant MeSH terms:
Crohn Disease
Disease Progression
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on September 29, 2014